Biocorrx (OTCMKTS:BICX) Releases Earnings Results

Biocorrx (OTCMKTS:BICX) released its quarterly earnings data on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02, Zacks reports.

Biocorrx Stock Down 45.7%

Shares of BICX traded down $0.13 during trading hours on Friday, reaching $0.15. 23,798 shares of the company traded hands, compared to its average volume of 6,947. Biocorrx has a 12 month low of $0.15 and a 12 month high of $1.28. The company’s fifty day moving average price is $0.32 and its two-hundred day moving average price is $0.35. The company has a market capitalization of $4.52 million, a price-to-earnings ratio of -0.95 and a beta of 0.19.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.